Effects of neuromuscular blockers on carnosine levels in rat skeletal muscle.
A 30-min treatment with neuromuscular blocking doses of either physostigmine or d-tubocurarine was associated with a 44% or 36% (respectively) reduction in rat skeletal muscle carnosine levels in vivo.